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The Cholera and Other Vibrio Illness Surveillance (COVIS) system is a national surveillance system for human 
infection with pathogenic species of the family Vibrionaceae, which cause vibriosis and cholera. The Centers for 
Disease Control and Prevention (CDC) maintains COVIS. Information from COVIS helps track Vibrio infections and 
determine host, food, and environmental risk factors for these infections.
CDC initiated COVIS in collaboration with the Food and Drug Administration and four Gulf Coast states 
(Alabama, Florida, Louisiana, and Texas) in 1989. Using the COVIS report form (available at http://www.cdc.gov/
nationalsurveillance/PDFs/CDC5279_COVISvibriosis.pdf ), participating health officials report cases of vibriosis 
and cholera. The case report includes clinical data, including information about underlying illness; detailed history 
of seafood consumption; detailed history of exposure to bodies of water, raw or live seafood or their drippings, or 
contact with marine life in the seven days before illness onset; and traceback information on implicated seafood. 
Before 2007, only cholera, which by definition is caused by infection with toxigenic Vibrio cholerae serogroup 
O1 or O139, was nationally notifiable. In January 2007, infection with other serogroups of V. cholerae and other 
species from the family Vibrionaceae also became nationally notifiable, as vibriosis. 
CDC requests that all State Health Departments send all Vibrio cholerae and Vibrio mimicus isolates to CDC for 
additional characterization. For V. cholerae, CDC identifies serogroups O1, O75, O139, and O141 and determines 
whether the isolate produces cholera toxin. For all Vibrio species (excluding V. cholerae), CDC accepts isolates 
for antimicrobial resistance testing and all outbreak isolates for identification. Although all Vibrio infections are 
nationally notifiable, many cases are likely not recognized because Vibrios are not easily identified on routine  
enteric media. A selective medium, such as thiosulfate citrate bile salts sucrose agar (TCBS), should be used.
This report summarizes human Vibrio infections occurring during 2012 reported to COVIS. Results are presented 
in two categories: (1) infection with pathogenic species of the family Vibrionaceae (other than toxigenic Vibrio 
cholerae serogroups O1 and O139), which cause vibriosis; this category includes infection with toxigenic V. 
cholerae of serogroups other than O1 and O139, and (2) infection with toxigenic V. 
cholerae serogroups O1 and O139, which cause cholera. While many Vibrio 
species are well-recognized human pathogens, the status of some species 
(including Photobacterium damselae subsp. damselae (formerly V. 
damsela), V. furnissii, V. metschnikovii, and V. cincinnatiensis) as human 
enteric or wound pathogens is less clear. 
Understanding the routes by which infection is transmitted is 
essential for control. For vibriosis, cases are summarized by place 
of exposure (travel-associated vs. domestically acquired). Travel-
associated cases are defined as infections in persons who reported 
international travel in the seven days before illness began; all 
other infections were defined as domestically-acquired cases. For 
domestically acquired vibriosis, transmission routes (foodborne, non-
foodborne, and unknown) are determined based on reported patient 
exposures and specimen sites (see Appendix for classification method).  
For toxigenic V. cholerae (all serogroups), exposures are summarized by 
place of exposure (travel-associated vs. domestically acquired) and 
then, if information is available, by source (such as consumption of 
contaminated seafood). 
This Gram-stain depicts flagellated Vibrio 
comma bacteria, a strain of V. cholerae.
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I. Vibriosis 
Pathogenic species of the family Vibrionaceae (excluding toxigenic V. cholerae O1 and O139)
In 2012, 944 Vibrio infections (excluding toxigenic V. cholerae O1 and O139) were reported to COVIS (Table 1). 
Among patients for whom information was available, 312 (35%) of 883 were hospitalized, and 50 (6%) of 846 
died. The most frequently reported species was V. parahaemolyticus, which was isolated from 431 (46%) of the 
944 patients. Of the patients infected with V. parahaemolyticus for whom information was available, 101 (25%) 
of 403 were hospitalized, and 6 (2%) of 390 died. V. alginolyticus was isolated from 182 (19%) of the 944 patients; 
of the patients for whom information was available, 20 (12%) of 162 were hospitalized; one death was reported. 
V. vulnificus was isolated from 119 (13%) of the 944 patients; of the patients for whom information was available, 
101 (87%) of 116 were hospitalized, and 34 (32%) of 106 died. 
Table 1. Vibriosis cases by species, selected patient demographic characteristics, and outcome, United States, 2012
Demographic Characteristics Outcomes
Genus and Species of 
Vibrionaceae Cases Age (years) Sex Hospitalizations Deaths
N % Median Range Male (n/N) % n/N % n/N %
V. parahaemolyticus 431 46 49 1-93 292/425 69 101/403 25 6/390 2
V. alginolyticus 182 19 31 2-85 117/181 65 20/162 12 1/152 1
V. vulnificus 119 13 61 7-93 103/118 87 101/116 87 34/106 32
V. cholerae (excluding 
toxigenic O1 and O139)* 68 7 49 1-89 40/67 60 31/65 48 1/65 2
V. fluvialis 58 6 63 6-90 31/56 55 26/57 46 3/53 6
V. mimicus 20 2 52 18-89 11/20 55 4/20 20 0/19 0
Grimontia hollisae  
(formerly V. hollisae) 15 2 55 21-84 10/13 77 9/13 69 1/13 8
V. furnissii 3 <1 50 8-70 1/3 33 1/3 33 0/3 0
V. harveyi 2 <1 73 70-75 1/2 50 1/2 50 1/2 50
V. metschnikovii 2 <1 62 47-77 1/2 50 1/2 50 0/2 0
Photobacterium damselae 
subsp. damselae  
(formerly V. damsela)
1 <1 69 69 0/0 0 0/1 0 0/1 0
Species not identified 37 4 49 4-81 22/37 59 14/33 42 2/35 2
Multiple species† 6 1 66 46-77 5/6 83 3/6 50 1/5 20
Total 944 100 50 1-93 634/930 68 312/883 35 50/846 6
*Includes 64 non-toxigenic V. cholerae (non-O1, non-O139 [55 cases], O1 [5 cases], O141 [1 case], non-O1 [1 case (not tested for O139)], no serogroup 
specified [2 cases]) and 4 toxigenic V. cholerae O141.
†The following combinations of Vibrio species were isolated from patients infected with multiple species: V. alginolyticus, V. parahaemolyticus (2 patients);  
V. fluvialis, V. parahaemolyticus (2 patients); V. mimicus, V. parahaemolyticus (1 patient); V. cholerae non-O1, non-O139, V. mimicus (1 patient). None of these 
are included in the rows for individual species.
Page 3 of 9April 2014
Geographic Location
Of the 944 vibriosis cases, 299 (32%) were reported from Gulf Coast states, 156 (17%) from Pacific Coast states, 
335 (35%) from Atlantic Coast states, and 154 (16%) from non-coastal states (Figure 1). 
The Vibrio species reported most frequently from Gulf Coast states were V. parahaemolyticus (25%),  
V. alginolyticus (25%), V. vulnificus (22%), and V. cholerae (excluding toxigenic V. cholerae O1 and O139) (10%).  
The Vibrio species reported most frequently from non-Gulf Coast states were V. parahaemolyticus (55%),  
V. alginolyticus (17%), and V. vulnificus (8%). 
Figure 1. Number of cases of Vibrio infections (excluding toxigenic V. cholerae O1 and O139), by state,  
2012 (N=944 from 42 states). 
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Transmission categories and reported exposures
Among the 944 vibriosis patients, 41 (4%) reported international travel in the seven days before illness began. 
Among the 903 domestically-acquired vibriosis cases, 492 (54%) were classified as confirmed or probable 
foodborne, 335 (37%) as confirmed or probable non-foodborne, and 76 (8%) as having an unknown transmission 
route (Figure 2).  Illnesses peaked in the summer months for all categories, but the peak was most pronounced for 
foodborne infections (Figure 3). 
Among the 211 patients with confirmed and probable foodborne vibriosis who reported eating a single seafood 
item (Table 2), 115 (55%) ate oysters (90% of whom consumed them raw), 27 (13%) ate clams (78% of whom 
consumed them raw), 22 (10%) ate finfish, and 13 (6%) ate shrimp.
For cases with non-foodborne transmission, 263 (79%) patients reported having skin exposure to a body of water 
within 7 days before illness began, 53 (16%) reported handling seafood, and 57 (17%) reported contact with 
marine wildlife. 
Figure 2. Domestically acquired vibriosis cases by transmission route and species, United States, 2010 (N=871). 
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Figure 3. Domestically-acquired vibriosis cases, by month of illness onset or specimen collection  
(when onset date not available) and transmission route, 2012 (N=903).
Month of illness onset
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
140
120
100
80
60
40
20
0
N
o.
 o
f c
as
es
Total confirmed and 
probable foodborne
Total confirmed and 
probable non-foodborne
Unknown
Table 2. Seafood exposures among 211 patients with domestically-acquired foodborne vibriosis who reported 
eating a single seafood item in the week before illness onset, 2012.
Mollusks Crustaceans Other
Oysters Clams Mussels Shrimp Lobster Crab Crayfish Other Shellfish* Finfish
†
Patients who ate 
single seafood item  
n (% of 211)
115 (55) 27 (13) 2 (1) 13 (6) 4 (2) 25 (12) 2 (1) 2 (1) 22 (10)
Patients who ate  
the single seafood 
item raw, n (% of n  
in row above)
104 (90) 21 (78) 1 (50) 0 (0) 0 (0) 5 (2) 1 (50) 0 (0) 6 (27)
* Other shellfish reported: scallops.
† Finfish reported: ahi, cod, mullet, salmon, swordfish, tilapia, trout, and tuna. 
Laboratory 
In 2012, 173 isolates were confirmed at CDC as V. parahaemolyticus; 41 serotypes of V. parahaemolyticus were 
identified: 16% were of the pandemic clone serotype O3:K6, 10% were O4:Kuknown,  10% O4:K12, 10% O1:Kuk, 
10% O3:Kuknown, and the remaining 21% consisted of  36 other serotypes (1 isolate each). 
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Toxigenic V. cholerae, excluding serogroups O1 and O139
Serogroup O141 
In 2012, four patients with toxigenic V. cholerae serogroup O141 infection were reported. None were hospitalized 
and none died. No patient reported travel; 2 reported recreational water exposure; one reported consumption of 
raw clams harvested from Barnegat Bay, New Jersey; and one had an unknown exposure, but reported drinking 
water from San Carlos Lake in Arizona, which had been closed due to elevated algae levels and dead fish. 
Serogroup O75
In 2012, no patients with toxigenic V. cholerae O75 infection were reported. 
Table 3. Cases of toxigenic V. cholerae O141 infections, 2012. 
State Age Sex Month of Illness onset
International 
Travel Exposure Serogroup
Missouri 36 M May No Swimming in the  Big Piney River, Missouri O141
Arizona 51 M Unknown No
Unknown, but reported 
exposure to San Carlos Lake, 
Arizona
O141
Texas 22 F June No Swimming in the  Guadalupe River, Texas O141
New Jersey 67 M July No Raw clams from  Barnegat Bay, New Jersey O141
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II. Cholera 
Serogroup O1 & O139
In 2012, 18 patients with toxigenic V. cholerae serogroup O1 infection were reported. Of the 18 patients, 67% 
were hospitalized and none died. Seventeen (94%) cases were travel-associated (10 with travel to Haiti, 3 to the 
Dominican Republic, and 4 to other cholera-affected countries). The remaining patient reported exposure to V. 
cholerae O1 in a laboratory. 
No cases of toxigenic V. cholerae O139 infection were reported. 
Table 4. Cases of toxigenic V. cholerae serogroup O1, biotype El Tor, infection, 2012.
State Age Sex Month of Illness Onset
International 
Travel Exposure Serotype
Maryland 69 F January Yes India Ogawa
New York City 1 M March Yes Bangladesh Ogawa
Florida 23 M April Yes Dominican Republic Ogawa
Pennsylvania 49 M May Yes Haiti Ogawa
New York City 51 F May Yes Dominican Republic Ogawa
Florida 26 F May Yes Haiti Ogawa
New York City 64 M May Yes Haiti Ogawa
Florida 65 F May Yes Haiti Ogawa
New York City 67 M June Yes Haiti Ogawa
Maryland 55 F June Yes Philippines Ogawa
Florida 32 F June Yes Haiti Unknown*
Texas 51 F July Yes Pakistan Inaba
Pennsylvania 36 M August Yes Dominican Republic Ogawa
Florida 61 M August Yes Resident of Haiti Ogawa
Massachusetts 37 F September No Laboratory Ogawa
Florida 77 F October Yes Haiti Ogawa
Florida 78 M October Yes Haiti Ogawa
Florida 82 F November Yes Resident of Haiti Ogawa
*The isolate did not agglutinate in O1 specific antisera but was confirmed as serogroup O1 by molecular characterization. 
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III. Publications using COVIS data, 2012 and 2013
Vugia DJ, Tabnak F, Newton AE, Hernandez M, Griffin PM. Impact of 2003 state regulation on raw oyster–associated 
Vibrio vulnificus illnesses and deaths, California, USA. Emerg Infect Dis. 2013 Aug;19(8):1276-80. 
Newton A, Kendall M, Vugia DJ, Henao OL, Mahon BE. Increasing rates of vibriosis in the United States, 1996-2010: 
review of surveillance data from 2 systems. Clin Infect Dis. 2012 Jun;54 Suppl 5:S391-5.
Appendix
Method for Classification of Transmission Routes in the Cholera and Other Vibrio Illness 
Surveillance (COVIS) System
I.    Exposure categories
To classify transmission routes, the first step is to categorize patient exposures. For a given illness episode, 
>1 patient exposure can be reported to COVIS; each reported exposure is categorized individually. If all 
exposures fall into a single category, then the report is considered to have a single exposure category. If not, 
the report is considered to have multiple exposure categories. For a given case, if any exposure is reported, 
we assume that other exposures for which information was not reported were not present. Exposures are 
classified using three categories:
1. Seafood consumption: Ingestion of seafood. Does not include touching seafood.
2. Marine/estuarine contact: Includes direct skin contact with marine/estuarine life, bodies of water,  
 or drippings from raw or live seafood. 
3. Unknown exposure: no exposure history reported.
II.    Specimen site categories
The next step in classifying transmission routes is to categorize reported specimen sites.  For a given illness 
episode, >1 specimen site can be reported; each reported site is categorized individually. If all specimen 
sites fall into a single category, then the report is considered to have a single specimen site category. If not, 
then the report is considered to have multiple specimen site categories.  Specimen sites are classified using 
five categories:
1. Gastrointestinal site (GI): stool, bile, appendix, rectum, gall bladder, colon 
2. Blood or other normally sterile site (sterile): blood, cerebrospinal fluid (CSF), peritoneal fluid, lumbar 
disc fluid, lymph node, bullae
3. Skin or soft tissue site (SST): wound, ear (other than otitis media and middle ear, which are included in 
‘other, non-sterile site’), appendage, tissue
4. Other, non-sterile site (ONS): urine, sputum, aspirate, bronchial washing, effusion, catheter,  
 endotracheal, eye, nasal, placenta, respiratory, sinus, tonsil
5. Unknown site (unknown): no specimen site reported or no site specified for ‘other’
Note: The lists of sites for each category above are not intended to be exhaustive. Rather, they reflect the 
sites actually reported to COVIS and can be updated, if new sites are reported.
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III.  Transmission route
The final step in classifying transmission involves review of exposure and specimen site categories for each 
reported case. Reports are classified into one of three transmission routes, foodborne, non-foodborne, and 
unknown, based on criteria below:
1. Single exposure category: seafood consumption
•	 Confirmed Foodborne: Vibrio isolated only from GI or sterile site OR Vibrio isolated from multiple 
specimen site categories, including a GI site. 
•	 Probable Foodborne: Vibrio isolated only from SST, ONS, or unknown sites OR Vibrio isolated from 
multiple specimen site categories, not including GI.
2. Single exposure category: marine/estuarine contact 
•	 Confirmed Non-foodborne: Vibrio isolated only from SST or sterile site OR Vibrio isolated from 
multiple specimen site categories, with SST reported.
•	 Probable Non-foodborne: Vibrio isolated only from GI, ONS, or unknown sites OR Vibrio isolated 
from multiple specimen site categories, not including SST.
3. Multiple exposure categories: both seafood consumption AND marine/estuarine contact 
•	 Confirmed Foodborne: Vibrio isolated only from a GI site OR Vibrio isolated from multiple specimen 
site categories, with GI reported and SST not reported.
•	 Confirmed Non-foodborne: Vibrio isolated only from a SST site OR Vibrio isolated from multiple 
specimen site categories, with SST reported and GI not reported. 
•	 Unknown: Vibrio isolated only from a sterile, ONS, or unknown site OR Vibrio isolated from multiple 
specimen site categories, including either 1) both GI and SST or 2) neither GI nor SST.
4. Unknown or no reported exposure (note that categorization is the same as for  
 multiple exposure categories) 
•	 Confirmed Foodborne: Vibrio isolated only from a GI site OR Vibrio isolated from multiple specimen 
site categories, with GI reported and SST not reported.
•	 Confirmed Non-foodborne: Vibrio isolated only from a SST site OR Vibrio isolated from multiple 
specimen site categories, with SST reported and GI not reported.
•	 Unknown: Vibrio isolated only from a sterile, ONS, or unknown site OR Vibrio isolated from multiple 
specimen site categories, including either 1) both GI and SST or 2) neither GI nor SST. 
NCEZID Atlanta: 
For more information please contact Centers for Disease Control and Prevention 
1600 Clifton Road NE, Atlanta, GA 30333 MS C-09 
Telephone: 1-404-639-2206  
Email: cdcinfo@cdc.gov
